qilu pharmaceutical hainan co.ltd.
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for qilu pharmaceutical hainan co.ltd. from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 6 transactions, with a transaction quantity of 1008.1 and a transaction weight of 4390.
- Year Transactions Quantity Weight
- 2025 41 3198.17 14752.54
- 2026 6 1008.1 4390
Bill of lading data
< 1/15 >- Trade date 2026/02/18 B/L No. ——
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers revi ve health care
- POLs —— PODs ipaf
- Supply area China Purchas area Pakistan
- Weight —— Amount 12692.31
- Hs code 30049099 Product tags gh,paclitaxel,clix,pc,injection,albumin,cancer medicine
- Product description CANCER MEDICINE PACLIXA (PACLITAXEL-ALBUMIN BOUND INJECTION 100MG) QTY=300 PCS TOTAL WEIGHT=25 KG Expand
- Trade date 2026/02/14 B/L No. 0263303
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers riconpharma india pvt.ltd.
- POLs —— PODs hyderabad
- Supply area China Purchas area India
- Weight —— Amount 43.61
- Hs code 30049099 Product tags 1 2m,bortezomib,injection,vial,3m
- Product description BORTEZOMIB INJECTION 3MG 1 2ML 2 5MG ML LIC NO SW ND CT 17 2024 000006356 NET QTY 360 VIAL BORTEZOMIB INJECTION 3MG 1 2ML 2 5MG ML LIC NO SW ND CT Expand
- Trade date 2026/02/14 B/L No. chsl537116086can
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers sagent c o eversana life science s
- POLs 57000, hulutao PODs 1703, savannah, ga
- Supply area China Purchas area United States
- Weight 2959kg Amount ——
- Hs code 848041 Product tags bortezomib,for injection,pemetrexed,mg pallet
-
Product description
BORTEZOMIB FOR INJECTION .MG PEMETREXED FOR INJECTION MG PEMETREXED FOR INJECTION MG PALLETS CONTAINING PACKAGES
Expand
- Trade date 2026/02/13 B/L No. 78468421463
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers ambica international
- POLs —— PODs ninoy aquino international airport
- Supply area China Purchas area Philippines
- Weight 53kg Amount 802804.42
- Hs code 30049089000 Product tags box,pharmaceutical,vent,irinotecan hydrochloride,sol,ion,iv infusion,qilu
- Product description 1000 BOXES QILU PHARMACEUTICAL VENTERA (IRINOTECAN HYDROCHLORIDE 20MG/ML SOLUTION FOR IV INFUSION) Expand
- Trade date 2026/02/02 B/L No. ——
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers al habib pharmaceuticals
- POLs —— PODs kpaf
- Supply area China Purchas area Pakistan
- Weight —— Amount 68523.01
- Hs code 30049099 Product tags bat,irit,vial,ah,itr,cancer medicine
- Product description CANCER MEDICINES) AHP-IRITO INJ 100MG/5ML (ITRINEOCAN) REG NO. 115766 BATCH NO. EB8E5004C M. 15-08-2025 E. 15-07-2027 (10419 VIALS @ US$. 6.50 PER VIAL) Expand
- Trade date 2026/01/19 B/L No. exdo61n0921790
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers hikma pharmaceuticals plc
- POLs 57078, yantian PODs 1401, norfolk, va
- Supply area China Purchas area United States
- Weight 1378kg Amount ——
- Hs code 848041 Product tags osa,for injection,prep
-
Product description
FOSAPREPITANT FOR INJECTION HTS:
Expand
- Trade date 2025/12/30 B/L No. 1166413
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers riconpharma india pvt.ltd.
- POLs —— PODs hyderabad
- Supply area China Purchas area India
- Weight —— Amount 24
- Hs code 30049099 Product tags osa,vial,for injection,prep
- Product description FOSAPREPITANT FOR INJECTION 150MG VIAL QTY 12 VIALS LIC NO SW OD 11 2025 0000018069FOSAPREPITANT FOR INJECTION 150MG VIAL QTY12 VIALS LIC Expand
- Trade date 2025/12/24 B/L No. ——
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers al habib pharmaceuticals
- POLs —— PODs kpaf
- Supply area China Purchas area Pakistan
- Weight —— Amount 19161.02
- Hs code 30049099 Product tags bat,cancer,irit,ah,medicine,ev,neotec
- Product description MEDICINES FOR CANCER) AHP-IRITO INJ 100MG/5ML (IRINEOTECAN) REG NO. 115766 BATCH NO. EB8E5004B M. 01-08-2025 E. 31-07-2027 (2500 PKS @ US$. 7.50 PER PKS) (PREVIOUS EVIDENCE KPAF-HC-30331-08-11-2025) Expand
- Trade date 2025/11/30 B/L No. bsvvbms2511025
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers mullan pharmaceutical inc.
- POLs 57078, yantian PODs 2704, los angeles, ca
- Supply area China Purchas area United States
- Weight 3248kg Amount ——
- Hs code 848041 Product tags injection
-
Product description
BUMETANIDE INJECTION ( . MG/ ML)
Expand
- Trade date 2025/11/25 B/L No. ——
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers lambda therapeutic research ltd.
- POLs —— PODs ahmedabad
- Supply area China Purchas area India
- Weight —— Amount 336
- Hs code 30049099 Product tags lysi,tablet,xtandi,testa,enzalutamide,abs
- Product description XTANDI ENZALUTAMIDE TABLETS 40MG 112X3=336 TABS FOR TESTAND ANALYSIS PURPOSE ONLYXTANDI ENZALUTAMIDE TABLETS 40MG 112X3336 TABS FOR TEST Expand
- Trade date 2025/11/25 B/L No. ——
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers lambda therapeutic research ltd.
- POLs —— PODs ahmedabad
- Supply area China Purchas area India
- Weight —— Amount 70
- Hs code 30049099 Product tags lysi,tablet,enzalutamide,amide,lye,abs,alu
- Product description ENZALUTAMIDE TABLETS 160MG 70X2=140 TABS FOR TEST AND ANALYSIS PURPOSE ONLYENZALUTAMIDE TABLETS 160MG 70X2140 TABS FOR TEST AND ANALY Expand
- Trade date 2025/11/13 B/L No. 91003047684792
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers hb human bioscience s.a.s.
- POLs —— PODs bogota
- Supply area China Purchas area Colombia
- Weight 12.8kg Amount 6095.45
- Hs code 3004902400 Product tags equipped with fixed dose drug
- Product description DO 2541806 PEDIDO TRAMITE: OC 497 DECLARACION(2-2) MERCANCIA UBICADA EN ZONA FRANCA BOGOTA CRA 106 N. 15A - 25 INT 141 OFICINA 501 PHARMAQUILA SAS //. FACTURA: HN241215 FECHA: 2025-03-28 PRODUCTO: MEDICAMENTO ONCOLOGICO REVOTRAIN 500 MG, NOMBRE COMERCIAL:REVOTRAIN 500 MG, PRINCIPIO ACTIVO: PEMETREXED DISODICO HEMIHEPTAHIDRATADO EQUIVALENTE A PEMETREXED, CONCENTRACION: 500 MG, INDICACIONES TERAPEUTICAS: INDICACIONES: MESOTELIOMA REVOTRAIN EN COMBINACION CON UN AGENTE PLATINO ESTA INDICADO PARA EL TRATAMIENTO DE PACIENTES CON MESOTELIOMA PLEURAL MALIGNO CUYA ENFERMEDAD NO ES RESECABLE O QUE DE CUALQUIER MODO NO SON CANDIDATOS A CIRUGIA CURATIVA. CANCER PULMONAR A CELULAS NO PEQUENAS, NO ESCAMOSAS - COMBINACION CON CISPLATINO. REVOTRAIN EN COMBINACION CON CISPLATINO, ESTA INDICADO PARA EL TRATAMIENTO EN PRIMERA LINEA DE PACIENTES CON CANCER PULMONAR A CELULAS NO PEQUENAS NO ESCAMOSAS LOCALMENTE AVANZADO O METASTASICO. CANCER PULMONAR A CELULAS NO PEQUENAS NO ESCAMOSAS - DESPUES DE QUIMIOTERAPIA PREVIA. REVOTRAI Expand
- Trade date 2025/11/13 B/L No. 91003047685049
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers hb human bioscience s.a.s.
- POLs —— PODs bogota
- Supply area China Purchas area Colombia
- Weight 3.6kg Amount 2844.55
- Hs code 3004902400 Product tags equipped with fixed dose drug
- Product description DO 2541806 PEDIDO TRAMITE: OC 497 DECLARACION(1-2) MERCANCIA UBICADA EN ZONA FRANCA BOGOTA CRA 106 N. 15A - 25 INT 141 OFICINA 501 PHARMAQUILA SAS //. FACTURA: HN241215 FECHA: 2025-03-28 PRODUCTO: MEDICAMENTO ONCOLOGICO REVOTRAIN 100 MG, NOMBRE COMERCIAL:REVOTRAIN 100 MG, PRINCIPIO ACTIVO: PEMETREXED, CONCENTRACION: 100 MG, INDICACIONES TERAPEUTICAS: MESOTELIOMA. PEMETREXED EN COMBINACION CON UN AGENTE PLATINO ESTA INDICADO PARA EL TRATAMIENTO DE PACIENTES CON MESOTELIOMA PLEURAL MALIGNO CUYA ENFERMEDADNO ES RESECABLE O QUE DE CUALQUIER MODO NO SON CANDIDATOS A CIRUGIA CURATIVA. CANCER PULMONAR A CELULAS NO PEQUENAS NO ESCAMOSAS-COMBINACION CON CISPLATINO. PEMETREXED EN COMBINACION CON CISPLATINO, ESTA INDICADO PARA EL TRATAMIENTO EN PRIMERA LINEA DE PACIENTES CON CANCER PULMONAR A CELULAS NO PEQUENAS NO ESCAMOSAS LOCALMENTE AVANZADO O METASTASICO. CANCER PULMONAR A CELULAS NO PEQUENAS NO ESCAMOSAS- DESPUES DE QUIMIOTERAPIA PREVIA, FORMA FARMACEUTICA: PL - POLVO LIOFILIZADO, TIPO DE EMPAQUE: CAJA PLEGADIZA C Expand
- Trade date 2025/11/08 B/L No. ——
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers al habib pharmaceuticals
- POLs —— PODs kpaf
- Supply area China Purchas area Pakistan
- Weight —— Amount 19160.94
- Hs code 30049099 Product tags bat,cancer,irit,ah,medicine,itr
- Product description MEDICINES FOR CANCER) AHP-IRITO INJ 100MG/5ML ITRINEOCAN REG NO. 115766 BATCH NO. EB8E5004A M. 15-08-2025 E. 15-07-2027 (2500 PKS @ US$. 7.50 PER PKS) Expand
- Trade date 2025/11/01 B/L No. ——
- Suppliers qilu pharmaceutical hainan co.ltd. Buyers cristalia produtos quimicos farmaceuticos ltd.
- POLs —— PODs - aeroporto internacional de viracopos
- Supply area China Purchas area Brazil
- Weight 69.37kg Amount 130911.71
- Hs code 29232000 Product tags pro,tria,nitrogen,bora,compost,tos,leci,tin,fin,nio,quat,foam,fabrica,mico,as e,hid,das,mica,sico,insumos,fun,dos,tura
- Product description SAIS E HIDRóXIDOS DE AMóNIO QUATERNáRIOS; LECITINAS E OUTROS FOSFOAMINOLíPIDOS, DE CONSTITUçãO QUíMICA DEFINIDA OU NãO|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS QUíMICOS BáSICOS|COMPOSTOS DE FUNCOES NITROGENADAS Expand
Partners
Total 26- Rank Company Transactions Per Detail
- 1 apotex inc. united statesbuyer,they trade on 2024-07-15 537 62.3% >
- 2 apotex corp indianpolis united statesbuyer,they trade on 2022-12-07 210 24.36% >
- 3 hikma pharmaceuticals plc united statesbuyer,they trade on 2026-01-19 26 3.02% >
- 4 hb human bioscience s.a.s. colombiabuyer,they trade on 2025-11-13 12 1.39% >
- 5 riconpharma india pvt.ltd. indiasupplier,they trade on 2026-02-14 9 1.04% > +View All
Products
Total 68- Products Transactions Per Detail
-
ondansetron injection
301 66.3% > -
cod
259 57.05% > -
daptomycin
81 17.84% > -
injection
65 14.32% > -
oxaliplatin injection
52 11.45% >
+View All
Hscode rank
Total 27- HSCode Name Transactions Per Detail
- HS 30049099 4 0.88% >
- HS 3004902400 3 0.66% >
- HS 300490 3 0.66% >
- HS 3004902900 2 0.44% >
- HS 30049099000 2 0.44% > +View All
Trading Area
Total 12- Area Transactions Per Detail
- united states 787 91.3% >
- india 19 2.2% >
- colombia 10 1.16% >
- brazil 9 1.04% >
- other 8 0.93% > +View All
Port statistics
Total 9- Port Name Transactions Per Detail
- yantian 397 46.06% >
- 57078, yantian 8 0.93% >
- hong kong 7 0.81% >
- shanghai 4 0.46% >
- shekou 3 0.35% > +View All
qilu pharmaceutical hainan co.ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as ondansetron injection，cod，daptomycin.
According to the 52wmb.com global trade database, as of 2026-02-18, the company has completed 868 international trades,
with its main trading regions covering united states，india,colombia etc.
The core products include HS30049099，HS3004902400，HS300490 etc,
often transported via yantian，port 57078, yantian, port hong kong etc,
and its main trading partners are apotex inc.，apotex corp indianpolis，hikma pharmaceuticals plc.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on qilu pharmaceutical hainan co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool